JP Morgan Partners and Warburg Pincus have emerged as potential bidders in the battle for Warner Chilcott, a Northern Ireland-based pharmaceuticals company.

The two are part of the consortium led by DLJ Merchant Banking Partners, the private equity arm of Credit Suisse, which is being advised by Credit Suisse First Boston.